Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation

Sleep

Volumn 33, Issue 7, 2010, Pages 909-918

  Hambrecht Wiedbusch, Viviane S ^a   Gauthier, Elizabeth A ^a   Baghdoyan, Helen A ^a   Lydic, Ralph ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Diazepam; Eszopiclone; GABAA receptor; Microdialysis; Zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; DIAZEPAM; ESZOPICLONE; HYPNOTIC AGENT; ZOLPIDEM;

ACETYLCHOLINE RELEASE; ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC STIMULATION; CONCENTRATION RESPONSE; DELTA RHYTHM; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAM; GABAERGIC TRANSMISSION; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PONS RETICULAR FORMATION; PRIORITY JOURNAL; RAT; SLEEP WAKING CYCLE;

EID: 77954354338     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/33.7.909     Document Type: Article

References (69)

1. Buysee DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep 2006;29:1155-73. (Pubitemid 44484809)
2. NIH-Statement. National Institutes of Health state of the science conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005. Sleep 2005;28:1049-57.
3. Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 2007;30:959-68.
4. Whiting PJ, Bonnert TP, McKernan RM, et al. Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann N Y Acad Sci 1999;868:645-53.
5. Krystal AD. Treating the health, quality of life, and functional impairments in insomnia. J Clin Sleep Med 2007;3:63-72.
6. Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 2005;6:487-95.
7. Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault C. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001;63:49-55. (Pubitemid 32125356)
8. Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 1994;48:25-40.
9. Grunstein R. Insomnia. Diagnosis and management. Aust Fam Physician 2002;31:995-1000.
10. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000;162:225-33. (Pubitemid 30073249)
11. Kanai T, Szerb JC. Mesencephalic reticular activating system and cortical acetylcholine output. Nature 1965;205:80-2.
12. Lydic R, Baghdoyan HA. Acetylcholine modulates sleep and wakefulness: a synaptic perspective. In: Monti JM, Pandi-Perumal SR, Sinton CM, eds. Neurochemistry of sleep and wakefulness. Cambridge: Cambridge University Press, 2008:109-43.
13. Lydic R, Baghdoyan HA. Sleep, anesthesiology, and the neurobiology of arousal state control. Anesthesiology 2005;103:1268-95. (Pubitemid 41692513)
14. Leonard TO, Lydic R. Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate. J Neurosci 1997;17:774-85. (Pubitemid 27024589)
15. Baghdoyan HA, Monaco AP, Rodrigo-Angulo ML, Assens F, McCarley RW, Hobson JA. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs. J Pharmacol Exp Ther 1984;231:173-80.
16. Bourgin P, Escourrou P, Gaultier C, Adrien J. Induction of rapid eye movement sleep by carbachol infusion into the pontine reticular formation in the rat. Neuroreport 1995;6:532-6.
17. Imeri L, Bianchi S, Angeli P, Mancia M. Selective blockade of different brain stem muscarinic receptor subtypes: effects on the sleep-wake cycle. Brain Res 1994;636:68-72.
18. Marks GA, Birabil CG. Enhancement of rapid eye movement sleep in the rat by cholinergic and adenosinergic agonists infused into the pontine reticular formation. Neuroscience 1998;86:29-37.
19. Shiromani PJ, Fishbein W. Continuous pontine cholinergic microinfusion via mini-pump induces sustained alterations in rapid eye movement (REM) sleep. Pharmacol Biochem Behav 1986;25:1253-61.
20. OB mice differ in the cholinergic modulation of sleep and breathing. J Appl Physiol 2005;98:918-29.
21. Coleman CG, Lydic R, Baghdoyan HA. M2 muscarinic receptors in pontine reticular formation of C57BL/6J mouse contribute to rapid eye movement sleep generation. Neuroscience 2004;126:821-30.
22. Lydic R, Douglas CL, Baghdoyan HA. Microinjection of neostigmine into the pontine reticular formation of C57BL/6J mouse enhances rapid eye movement sleep and depresses breathing. Sleep 2002;25:835-41. (Pubitemid 35424525)
23. Sanford LD, Tang X, Xiao J, Ross RJ, Morrison AR. GABAergic regulation of REM sleep in reticularis pontis oralis and caudalis in rats. J Neurophysiol 2003;90:938-45.
24. Xi MC, Morales FR, Chase MH. Evidence that wakefulness and REM sleep are controlled by a GABAergic pontine mechanism. J Neurophysiol 1999;82:2015-9.
25. Marks GA, Sachs OW, Birabil CG. Blockade of GABA, type A, receptors in the rat pontine reticular formation induces rapid eye movement sleep that is dependent upon the cholinergic system. Neuroscience 2008;156:1-10.
26. A receptors inhibit acetylcholine release in cat pontine reticular formation: implications for REM sleep regulation. J Neurophysiol 2004;92:2198-206.
27. Hambrecht VS, Baghdoyan HA, Lydic R. Microdialysis delivery of eszopiclone, zolpidem and diazepam to the pontine reticular formation (PRF) of rat increases PRF acetylcholine (ACh) release. Program No. 285.16, Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, Online. 2008.
28. Hambrecht VS, Baghdoyan HA, Lydic R. Pontine reticular formation (PRF) administration of diazepam and zolpidem, but not eszopiclone, increases electroencephalogram (EEG) delta power in Sprague-Dawley rat. Sleep 2009; 32 (Abstract Suppl):0028.
29. Baghdoyan HA, Lydic R, Fleegal MA. M2 muscarinic autoreceptors modulate acetylcholine release in the medial pontine reticular formation. J Pharmacol Exp Ther 1998;286:1446-52. (Pubitemid 29135561)
30. Materi LM, Rasmusson DD, Semba K. Inhibition of synaptically evoked cortical acetylcholine release by adenosine: An in vivo microdialysis study in the rat. Neuroscience 2000;97:219-26.
31. Douglas CL, Baghdoyan HA, Lydic R. Postsynaptic muscarinic M1 receptors activate prefrontal cortical EEG of C57BL/6J mouse. J Neurophysiol 2002;88:3003-9.
32. Osman NI, Baghdoyan HA, Lydic R. Morphine inhibits acetylcholine release in rat prefrontal cortex when delivered systemically or by microdialysis to basal forebrain. Anesthesiology 2005;103:779-87.
33. Watson CJ, Soto-Calderon H, Lydic R, Baghdoyan HA. Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness. Sleep 2008;31:453-64.
34. Vanini G, Watson CJ, Lydic R, Baghdoyan HA. γ-Aminobutyric acid-mediated neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia. Anesthesiology 2008;109:978-88.
35. Zhu Z, Bowman HR, Baghdoyan HA, Lydic R. Morphine increases acetylcholine release in the trigeminal nuclear complex. Sleep 2008;31:1629-37.
36. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Sixth ed: Elsevier, 2007.
37. A-hypocretin receptor interaction in the pontine reticular formation. Sleep 2010;(In Press).
38. Van Dort CJ, Baghdoyan HA, Lydic R. Adenosine A1 and A2A receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. J Neurosci 2009;29:871-81.
39. B receptors in mammalian brain: potential targets for drug development. Drug Dev Res 1990;21:161-7.
40. Whiting PJ. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today 2003;8:445-50.
41. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 1995;359:154-94.
42. A receptor agonists. J Clin Psychiatry 2007;68 (Suppl 5):6-12.
43. A receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci 2001;22:188-94.
44. A receptors. Trends Pharmacol Sci 1997;18:425-9.
45. A receptors. Trends Pharmacol Sci 1995;16:162-8.
46. 36Cl ion flux. Mol Pharmacol 2001;59:1108-18.
47. Carlson JN, Haskew R, Wacker J, Maisonneuve IM, Glick SD, Jerussi TP. Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite. Eur J Pharmacol 2001;415:181-9.
48. A) receptor are different. J Med Chem 2008;51:7243-52.
49. Vyazovskiy VV, Tobler I, Winsky-Sommerer R. Alteration of behavior in mice by muscimol is associated with regional electroencephalogram synchronization. Neuroscience 2007;147:833-41.
50. A receptor agonist muscimol into the pontine reticular nucleus, oral part (PnO) of C57BL/6J (B6) mouse. Sleep 2009;32 (Abstract Suppl):0014.
51. A receptor subtype and state specificity. Proc Natl Acad Sci U S A 2004;101:3674-9.
52. Chen HY, Kuo TB, Shaw FZ, Lai CJ, Yang CC. Sleep-related vagotonic effect of zolpidem in rats. Psychopharmacology (Berl) 2005;181:270-9.
53. A receptor subtype. Proc Natl Acad Sci U S A 2001;98:6464-9.
54. Liang CL, Marks GA. A novel GABAergic afferent input to the pontine reticular formation: the mesopontine GABAergic column. Brain Res 2009;1297:32-40.
55. Watson CJ, Lydic R, Baghdoyan HA. Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine. Neuroscience 2007;144:375-86.
56. Xi M, Chase MH. Effects of eszopiclone and zolpidem on sleep and waking states in the adult guinea pig. Sleep 2008;31:1043-51.
57. Yoshimoto M, Higuchi H, Kamata M, Yoshida K, Shimizu T, Hishikawa Y. The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats. Eur Neuropsychopharmacol 1999;9:29-35.
58. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003;26:793-9.
59. Kodama T, Takahashi Y, Honda Y. Enhancement of acetylcholine release during paradoxical sleep in the dorsal tegmental field of the cat brain stem. Neurosci Lett 1990;114:277-82.
60. Leonard TO, Lydic R. Nitric oxide synthase inhibition decreases pontine acetylcholine release. Neuroreport 1995;6:1525-9.
61. Jones BE, Beaudet A. Distribution of acetylcholine and catecholamine neurons in the cat brainstem: a choline acetyltransferase and tyrosine hydroxylase immunohistochemical study. J Comp Neurol 1987;261:15-32.
62. Lydic R, Baghdoyan HA. Pedunculopontine stimulation alters respiration and increases ACh release in the pontine reticular formation. Am J Physiol 1993;264:R544-R54. (Pubitemid 23109903)
63. A receptor-mediated responses in pedunculopontine neurons. Sleep 2009;32:879-87.
64. A receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000;101:815-50.
65. A receptor subtypes. Curr Top Med Chem 2002;2:795-816.
66. Schiff ND. Central thalamic contributions to arousal regulation and neurological disorders of consciousness. Ann NY Acad Sci 2008;1129:105-18.
67. Schiff ND. Recovery of consciousness after brain injury: a mesocircuit hypothesis. Trends Neurosci 2010;33:1-9.
68. Schiff ND, Posner JB. Another "Awakenings". Ann Neurol 2007;62:5-6.
69. DeMarco GJ, Baghdoyan HA, Lydic R. Carbachol in the pontine reticular formation of C57BL/6J mouse decreases acetylcholine release in prefrontal cortex. Neuroscience 2004;123:17-29. (Pubitemid 37518472)